143 related articles for article (PubMed ID: 7510027)
1. Praziquantel (antischistosomal drug): is it clastogenic, co-clastogenic or anticlastogenic?
Anwar WA
Mutat Res; 1994 Mar; 305(2):165-73. PubMed ID: 7510027
[TBL] [Abstract][Full Text] [Related]
2. Reduction in chromosomal damage in schistosomiasis patients after treatment with praziquantel.
Anwar WA; Rosin MP
Mutat Res; 1993 Jan; 298(3):179-85. PubMed ID: 7678152
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of benzene clastogenicity by praziquantel in mice.
Anwar WA; Au WW; Ramanujam VM; Legator MS
Mutat Res; 1989 Mar; 222(3):283-9. PubMed ID: 2922012
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal damage in urothelial cells from Egyptians with chronic Schistosoma haematobium infections.
Rosin MP; Anwar W
Int J Cancer; 1992 Feb; 50(4):539-43. PubMed ID: 1537619
[TBL] [Abstract][Full Text] [Related]
5. Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients.
Rosin MP; Saad el Din Zaki S; Ward AJ; Anwar WA
Mutat Res; 1994 Mar; 305(2):283-92. PubMed ID: 7510039
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of clastogenic and co-clastogenic activity of cremophore with benzene in mice.
Au WW; Anwar W; Paolini M; Ramanujam S; Cantelli-Forti G
Carcinogenesis; 1991 Jan; 12(1):53-7. PubMed ID: 1988182
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on the efficacy of praziquantel and albendazole in the treatment of urinary schistosomiasis in Adim, Cross River State, Nigeria.
Ben SA; Useh MF
Int Health; 2017 Sep; 9(5):288-293. PubMed ID: 28911129
[TBL] [Abstract][Full Text] [Related]
8. Egypt: The flatworm's revenge.
Sarant L
Nature; 2017 Nov; 551(7679):S46-S47. PubMed ID: 29117163
[No Abstract] [Full Text] [Related]
9. Cross sectional study of schistosomiasis among military recruits in Alexandria.
Farghaly AG
J Egypt Public Health Assoc; 1992; 67(5-6):593-605. PubMed ID: 1294684
[TBL] [Abstract][Full Text] [Related]
10. Schistosomiasis haematobia: histopathological course determined by cystoscopy in a patient in whom praziquantel treatment failed.
Silva IM; Pereira Filho E; Thiengo R; Ribeiro PC; Conceição MJ; Panasco M; Lenzi HL
Rev Inst Med Trop Sao Paulo; 2008; 50(6):343-6. PubMed ID: 19082376
[TBL] [Abstract][Full Text] [Related]
11. Inflammation, chromosomal instability, and cancer: the schistosomiasis model.
Rosin MP; Anwar WA; Ward AJ
Cancer Res; 1994 Apr; 54(7 Suppl):1929s-1933s. PubMed ID: 8137314
[TBL] [Abstract][Full Text] [Related]
12. Molecular cytogenetic analysis of buccal cells and lymphocytes from benzene-exposed workers.
Surrallés J; Autio K; Nylund L; Järventaus H; Norppa H; Veidebaum T; Sorsa M; Peltonen K
Carcinogenesis; 1997 Apr; 18(4):817-23. PubMed ID: 9111220
[TBL] [Abstract][Full Text] [Related]
13. Ultrasonographic assessment of urinary tract lesions due to Schistosoma haematobium in Niger after four consecutive years of treatment with praziquantel.
Laurent C; Lamothe F; Develoux M; Sellin B; Mouchet F
Trop Med Parasitol; 1990 Jun; 41(2):139-42. PubMed ID: 2116659
[TBL] [Abstract][Full Text] [Related]
14. Reduction of pathological findings in urine and bladder lesions in infection with Schistosoma haematobium after treatment with praziquantel.
Doehring E; Reider F; Schmidt-Ehry G; Ehrich JH
J Infect Dis; 1985 Oct; 152(4):807-10. PubMed ID: 3930620
[TBL] [Abstract][Full Text] [Related]
15. Inflammation dynamics after praziquantel treatment of Schistosoma haematobium reflected by urinary eosinophil cationic protein.
Stecher CW; Fofana HKM; Madsen H; Wilson S; Keita AD; Landouré A; Traoré MS; Vennervald BJ; Reimert CM; Sacko M
Trans R Soc Trop Med Hyg; 2017 Jul; 111(7):316-324. PubMed ID: 29165707
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of praziquantel and Ro 15-5458, a 9-acridanone-hydrazone derivative, against Schistosoma haematobium.
Guirguis FR
Arzneimittelforschung; 2003; 53(1):57-61. PubMed ID: 12608016
[TBL] [Abstract][Full Text] [Related]
17. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
[TBL] [Abstract][Full Text] [Related]
18. Use of the fluorescent micronucleus assay to detect the genotoxic effects of radiation and arsenic exposure in exfoliated human epithelial cells.
Moore LE; Warner ML; Smith AH; Kalman D; Smith MT
Environ Mol Mutagen; 1996; 27(3):176-84. PubMed ID: 8625953
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound scanning for detecting morbidity due to Schistosoma haematobium and its resolution following treatment with different doses of praziquantel.
Hatz C; Mayombana C; de Savigny D; MacPherson CN; Koella JC; Degrémont A; Tanner M
Trans R Soc Trop Med Hyg; 1990; 84(1):84-8. PubMed ID: 2111949
[TBL] [Abstract][Full Text] [Related]
20. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates.
El-Khoby T; Galal N; Fenwick A; Barakat R; El-Hawey A; Nooman Z; Habib M; Abdel-Wahab F; Gabr NS; Hammam HM; Hussein MH; Mikhail NN; Cline BL; Strickland GT
Am J Trop Med Hyg; 2000 Feb; 62(2 Suppl):88-99. PubMed ID: 10813505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
